A carregar...
Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment trial
INTRODUCTION: The Strategic Timing of AntiRetroviral Treatment (START) trial has recruited antiretroviral-naïve individuals with high CD4 cell counts from all world regions. We describe the distribution of cardiovascular (CVD) risk factors, overall and by geographic region, at study baseline. METHOD...
Na minha lista:
| Publicado no: | HIV Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4341949/ https://ncbi.nlm.nih.gov/pubmed/25711323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12233 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|